Abrahim Al‐Mamgani

3.9k total citations
86 papers, 2.8k citations indexed

About

Abrahim Al‐Mamgani is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, Abrahim Al‐Mamgani has authored 86 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Otorhinolaryngology, 39 papers in Pulmonary and Respiratory Medicine and 31 papers in Radiation. Recurrent topics in Abrahim Al‐Mamgani's work include Head and Neck Cancer Studies (52 papers), Advanced Radiotherapy Techniques (31 papers) and Head and Neck Surgical Oncology (20 papers). Abrahim Al‐Mamgani is often cited by papers focused on Head and Neck Cancer Studies (52 papers), Advanced Radiotherapy Techniques (31 papers) and Head and Neck Surgical Oncology (20 papers). Abrahim Al‐Mamgani collaborates with scholars based in Netherlands, United States and Denmark. Abrahim Al‐Mamgani's co-authors include Peter C. Levendag, Wilma D. Heemsbergen, Joos V. Lebesque, Peter van Rooij, Ben Heijmen, Lisa Tans, Luca Incrocci, Michel F.H. Dielwart, Annerie Slot and David N. Teguh and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Abrahim Al‐Mamgani

83 papers receiving 2.8k citations

Peers

Countries citing papers authored by Abrahim Al‐Mamgani

Since Specialization

Citations

This map shows the geographic impact of Abrahim Al‐Mamgani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abrahim Al‐Mamgani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abrahim Al‐Mamgani more than expected).

Fields of papers citing papers by Abrahim Al‐Mamgani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abrahim Al‐Mamgani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abrahim Al‐Mamgani. The network helps show where Abrahim Al‐Mamgani may publish in the future.

Co-authorship network of co-authors of Abrahim Al‐Mamgani

This figure shows the co-authorship network connecting the top 25 collaborators of Abrahim Al‐Mamgani. A scholar is included among the top collaborators of Abrahim Al‐Mamgani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abrahim Al‐Mamgani. Abrahim Al‐Mamgani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin‐based chemoradiotherapy in patients with head and neck squamous cell carcinoma 2024 ·Head & Neck ·(unknown), (unknown), (unknown), (unknown), Jan Paul de Boer, Lisette van der Molen, (unknown), Abrahim Al‐Mamgani, Katarzyna Jóźwiak, Lot A. Devriese, Remco de Bree, Charlotte L. Zuur	1
2	Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study) 2023 ·Clinical and Translational Radiation Oncology ·Abrahim Al‐Mamgani, Rob Kessels, (unknown), Arash Navran, (unknown), Jeroen B. van de Kamer, Jan‐Jakob Sonke, Wouter V. Vogel	3
3	Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients 2021 ·Radiotherapy and Oncology ·(unknown), Simon van Kranen, (unknown), Olga Hamming‐Vrieze, Abrahim Al‐Mamgani, Jan‐Jakob Sonke	2
4	Protocolised way to cope with anatomical changes in head & neck cancer during the course of radiotherapy 2019 ·Technical Innovations & Patient Support in Radiation Oncology ·Suzanne van Beek, (unknown), Olga Hamming‐Vrieze, Abrahim Al‐Mamgani, Arash Navran, P. Remeijer, Jeroen B. van de Kamer	18
5	The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective Study 2016 ·PLoS ONE ·(unknown), Renske Fles, (unknown), (unknown), (unknown), (unknown), Karolina Sikorska, C. René Leemans, Marjanka K. Schmidt, Abrahim Al‐Mamgani, Maarten A. Wildeman, Sofia Mubarika Haryana, Sagung Rai Indrasari, I. Bing Tan	11
6	Inter- and Intrafraction Target Motion in Highly Focused Single Vocal Cord Irradiation of T1a Larynx Cancer Patients 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Stefan L.S. Kwa, Abrahim Al‐Mamgani, Sarah Osman, (unknown), Peter C. Levendag, Ben Heijmen	19
7	Dose Uncertainties in IMPT for Oropharyngeal Cancer in the Presence of Anatomical, Range, and Setup Errors 2013 ·International Journal of Radiation OncologyBiologyPhysics ·A. Kraan, Steven van de Water, David N. Teguh, Abrahim Al‐Mamgani, T. R. Madden, Hanne M. Kooy, Ben Heijmen, Mischa S. Hoogeman	87
8	Brachytherapy or stereotactic body radiotherapy boost for early-stage oropharyngeal cancer: Comparable outcomes of two different approaches 2013 ·Oral Oncology ·Abrahim Al‐Mamgani, Peter van Rooij, Aniel Sewnaik, Robert Mehilal, Lisa Tans, Gerda M. Verduijn, Robert J. Baatenburg de Jong	15
9	A prospective evaluation of patient-reported quality-of-life after (chemo)radiation for oropharyngeal cancer: Which patients are at risk of significant quality-of-life deterioration? 2013 ·Radiotherapy and Oncology ·Abrahim Al‐Mamgani, Peter van Rooij, Lisa Tans, Gerda M. Verduijn, Aniel Sewnaik, Robert J. Baatenburg de Jong	54
10	Long-term results of the Dutch randomized prostate cancer trial: Impact of dose-escalation on local, biochemical, clinical failure, and survival 2013 ·Radiotherapy and Oncology ·Wilma D. Heemsbergen, Abrahim Al‐Mamgani, Annerie Slot, Michel F.H. Dielwart, Joos V. Lebesque	145
11	Unilateral neck irradiation for well-lateralized oropharyngeal cancer 2013 ·Radiotherapy and Oncology ·Abrahim Al‐Mamgani, Peter van Rooij, D. Fransen, Peter C. Levendag	48
12	Radiotherapy with rectangular fields is associated with fewer clinical failures than conformal fields in the high-risk prostate cancer subgroup: Results from a randomized trial 2013 ·Radiotherapy and Oncology ·Wilma D. Heemsbergen, Abrahim Al‐Mamgani, Marnix G. Witte, Marcel van Herk, Joos V. Lebesque	23
13	Highly-conformal intensity-modulated radiotherapy reduced toxicity without jeopardizing outcome in patients with paranasal sinus cancer treated by surgery and radiotherapy or (chemo)radiation 2012 ·Oral Oncology ·Abrahim Al‐Mamgani, Dominiek Monserez, Peter van Rooij, Gerda M. Verduijn, José A. Hardillo, Peter C. Levendag	22
14	Long-term Outcomes and Quality of Life of 186 Patients With Primary Parotid Carcinoma Treated With Surgery and Radiotherapy at the Daniel den Hoed Cancer Center 2012 ·International Journal of Radiation OncologyBiologyPhysics ·Abrahim Al‐Mamgani, Peter van Rooij, Gerda M. Verduijn, Cees A. Meeuwis, Peter C. Levendag	70
15	Toxicity, quality of life, and functional outcomes of 176 hypopharyngeal cancer patients treated by (Chemo)radiation: The impact of treatment modality and radiation technique 2012 ·The Laryngoscope ·Abrahim Al‐Mamgani, Robert Mehilal, (unknown), Lisa Tans, Aniel Sewnaik, Peter C. Levendag	35
16	Local control in advanced cancer of the nasopharynx: Is a boost dose by endocavitary brachytherapy of prognostic significance? 2012 ·Brachytherapy ·Peter C. Levendag, (unknown), (unknown), (unknown), Maarten A. Wildeman, Inge Noever, Inger‐Karine K. Kolkman‐Deurloo, Abrahim Al‐Mamgani, (unknown), (unknown), David N. Teguh	19
17	Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature 2012 ·European Archives of Oto-Rhino-Laryngology ·Abrahim Al‐Mamgani, Peter van Rooij, Robert Mehilal, Lisa Tans, Peter C. Levendag	67
18	IMRT for Image-Guided Single Vocal Cord Irradiation 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Sarah Osman, Eleftheria Astreinidou, Hans C.J. de Boer, (unknown), Sebastiaan Breedveld, P. Voet, Abrahim Al‐Mamgani, Ben Heijmen, Peter C. Levendag	42
19	Dose Escalation and Quality of Life in Patients With Localized Prostate Cancer Treated With Radiotherapy: Long-Term Results of the Dutch Randomized Dose-Escalation Trial (CKTO 96-10 Trial) 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Abrahim Al‐Mamgani, Wim L.J. van Putten, Gerard J. van der Wielen, Peter C. Levendag, Luca Incrocci	38
20	Three-Dimensional Dose Addition of External Beam Radiotherapy and Brachytherapy for Oropharyngeal Patients Using Nonrigid Registration 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Eliana Vásquez Osorio, Mischa S. Hoogeman, David N. Teguh, Abrahim Al‐Mamgani, Inger‐Karine K. Kolkman‐Deurloo, Luiza Bondar, Peter C. Levendag, Ben Heijmen	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact